Patents by Inventor Sanjeewa Senadheera

Sanjeewa Senadheera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11820835
    Abstract: The present technology provides compounds of Formula I (or pharmaceutically acceptable salts and/or solvates thereof) that are useful in treating a CNS-related disorder such as schizophrenia, schizoaffective disorder, migraine, depression, pain, drug addiction, drug use, and/or drug seeking behavior. Also provided are compositions, medicaments, and methods including such compounds.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: November 21, 2023
    Assignees: UNIVERSITY OF KANSAS, UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Jane Aldrich, Sanjeewa Senadheera, Jay McLaughlin
  • Publication number: 20210024576
    Abstract: The present technology provides compounds of Formula I (or pharmaceutically acceptable salts and/or solvates thereof) that are useful in treating a CNS-related disorder such as schizophrenia, schizoaffective disorder, migraine, depression, pain, drug addiction, drug use, and/or drug seeking behavior. Also provided are compositions, medicaments, and methods including such compounds.
    Type: Application
    Filed: March 22, 2019
    Publication date: January 28, 2021
    Inventors: Jane Aldrich, Sanjeewa Senadheera, Jay McLaughlin